Skip to content

Immunome Inc.

IMNM · XNAS

CIK 1472012fmd_0CSM7VSHNJ10GZM8XR012V6Q1CManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2019 to Sep 30, 2026, 29 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading